Study of European registry data for advanced skin cancers
Part of Cancer clinical trials.
This study uses information from a European registry to learn how real-world treatments work for advanced non-melanoma skin cancers. It may help doctors improve care in the future, especially for people who have had surgery and radiation or who cannot have curative treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your case is already in the European NMSC registry and meets their data-quality standards
- You fit one of these groups: resected high-risk cSCC getting only postoperative radiation or watchful waiting
- You fit one of these groups: advanced cSCC where curative surgery or radiation is not an option in routine care
- You fit one of these groups: advanced BCC where curative surgery or radiation is not an option in routine care
- You are not currently receiving treatment as part of another clinical trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how people with advanced basal cell carcinoma (a type of skin cancer that is hard to treat or has spread) are cared for and what happens over time. It does not test any new treatments, but helps doctors learn more about the disease.
This study looks at how doctors stage (classify the extent of) a type of skin cancer called cutaneous squamous cell carcinoma. You may be helping researchers by allowing your clinical data to be used for research.
This trial tests a combination of an immunotherapy drug (cemiplimab) and a special kind of radiation for a type of skin cancer called cutaneous squamous cell carcinoma. It is designed for people whose cancer has come back or is hard to treat with standard surgery or radiation.
This trial studies a blood test (ctDNA) in people with a type of skin cancer called cutaneous squamous cell carcinoma. It aims to see if the test can help track the cancer and guide treatment decisions.
This study follows patients newly diagnosed with cutaneous squamous cell carcinoma (a type of skin cancer) who are beginning systemic treatment (medicine that affects the whole body). Researchers want to understand how these treatments work and track patient outcomes over time.
This study is looking at how well a new skin imaging tool called LC-OCT works in everyday skin cancer clinics in the Netherlands. It will help doctors understand if this tool can accurately identify skin cancers without needing as many biopsies.
Hear when a new Basal Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.